Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell William Jenkins, David Lieb, Jonathan H. Chen, Dennie Tompers Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul Hoover, Alexandra–Chloé Villani, Elena V. Ivanova, Andrew J. Portell, Patrick Hall Lizotte, Amir Reza Aref, Jean-Pierre Eliane, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha Meda Reddy, and 10 more

View at source ↗PDF ↗Article2,052 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1016/j.cell.2018.10.038
Published
Nov 1, 2018
Venue
Cell
DOI
10.1016/j.cell.2018.10.038
PubMed
30388456
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics